课题基金 / 基金详情

The influence of ApoE4 on signaling & poor outcome after traumatic brain injury

The influence of ApoE4 on signaling & poor outcome after traumatic brain injury
ApoE4 对信号传导的影响
批准号:
10266025
负责人:
Naomi Ledene Sayre
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-06-30
关键词:
AcuteAdvisory CommitteesAffectAfghanistanAgingAllelesAmyloid beta-ProteinApolipoprotein EAstrocytesAttenuatedBehaviorBindingBiologyBrainBrain InjuriesCell Culture TechniquesCell DeathCell SurvivalCell membraneCellsChronicCoculture TechniquesCritical ThinkingCytokine SignalingCytosolDataDisease ProgressionEdemaEndocytosisEndosomesEnvironmentEvaluationFosteringFundingFutureGJB6 geneGenetic RecombinationGoalsHeadacheHealthImpairmentIncidenceInflammationInflammatoryInjuryInterventionInvestigationIraqJournalsK-Series Research Career ProgramsKnock-outLDL-Receptor Related Protein 1LDL-Receptor Related ProteinsLeadLearningLinkLipidsLipoproteinsManuscriptsMeasurementMeasuresMediatingMemory LossMentorsMilitary PersonnelModelingMusNecrosisNeurodegenerative DisordersNeurologicNeurologic DeficitNeurological ModelsNeuronsNeurosciencesOutcomePathologicPathologyPatientsPlayPost-Traumatic Stress DisordersProteinsPublishingRecording of previous eventsRecoveryRecyclingResearchResearch PersonnelRiskRoleSignal TransductionStressStructureSurfaceSystemTNF geneTNFRSF1A geneTestingTimeTrainingTraumatic Brain InjuryVeteransWarWorkapolipoprotein E-3apolipoprotein E-4blood-brain barrier permeabilizationcareercell typecytokinedesigneffective therapyimprovedinnovationmilitary veteranmouse modelnegative affectnervous system disorderneuropathologynoveloutcome predictionpreventprotein expressionreceptorreceptor mediated endocytosisreceptor recyclingresponseresponse to injuryshear stresssymposiumtraining opportunitytumor

项目摘要

项目成果

Naomi Ledene Sayre的其他基金

相似基金

相关文献

中文摘要
翻译
这份职业发展奖提案旨在定义预测以下结果的潜在机制 创伤性脑损伤(TBI),同时为申请者提供 弗吉尼亚州TBI影响大约15%的军事人口。退伍军人反复接受创伤性脑损伤正在增加 患上长期神经退行性疾病的风险。治疗选择有限,主要是因为 脑外伤所致神经功能障碍背后的病理机制尚不清楚。 载脂蛋白E(ApoE)有几个等位基因,表达E4等位基因的患者预后较差。 尤其是在脑损伤后的长期内。尽管有广泛的研究集中在载脂蛋白E4等位基因上,但没有一项研究可以 研究发现,主要的载脂蛋白E受体,低密度脂蛋白相关蛋白1(LRP1), 关于颅脑损伤后的结果。然而,有证据表明,LRP1可以在调节脑损伤转归中发挥作用。 -LRP1从质膜和胞浆中去除多种细胞蛋白,并发挥作用 在决定质膜蛋白表达方面起着重要作用。 载脂蛋白E4通过与LRP1结合并经历受体介导的内吞作用进入细胞。与其他 载脂蛋白E等位基因(E2、E3)、载脂蛋白E4内吞作用和受体循环受损。在LRP1情况下,受损 再循环被认为可以极大地改变LRP1作为清除受体的能力,从而改变环境 质膜上表达的蛋白质,从而改变细胞对损伤的反应。对于这项提议, 我的重点是了解LRP1在单一细胞类型--星形胶质细胞中对脑损伤病理的贡献。不 星形胶质细胞不仅是大脑中载脂蛋白E的主要生产者,它们还在决定 通过限制颅脑损伤后损害的二次扩散而产生的结果。我的工作假设是关键的LRP1 ApoE4结合星形胶质细胞的功能被破坏,从而调节正常的细胞反应和 使脑损伤后的炎症和细胞死亡变得敏感。我的研究策略将检验这一假设 同时还提供明确的培训目标和职业机会,以发展独立性。 目的1验证星形胶质细胞LRP1缺失会恶化脑损伤预后的假说。星形胶质细胞特异性LRP1 小鼠已经产生,小鼠脑损伤模型将在急性和慢性结果中测试结果。目标2 将检验载脂蛋白E4对脑损伤预后的影响取决于LRP1的假设。类脑损伤细胞培养模型 将机械测试载脂蛋白E4和LRP1对细胞存活的影响。将生成一个新的鼠标行 通过将ApoE4靶向替换小鼠引入星形胶质细胞-LRP1基因敲除模型,然后对 脑损伤后的结果将进行类似于目标1的测试。目标3测试载脂蛋白E4通过以下方式恶化结果的假设 通过炎症性肿瘤坏死因子受体1(TNFR1)增加信号,提高细胞因子 刺激细胞死亡。这一目标将通过使用细胞培养模型进行机械测试,以测试 ApoE4和LRP1对TNFR1质膜表达、再循环和TNFR1介导的细胞死亡的影响。 我的职业目标是成为退伍军人管理局内一名成功的独立调查员,最终获得 值得资助,并为创伤性脑损伤退伍军人的更好结果做出贡献。我已经组建了一个团队,其中包括 LRP1生物学、神经科学领域的专家,最重要的是,TBI领域的专家。科学目标将会 为我的职业生涯做好准备,研究脑损伤对小鼠模型的影响,同时职业目标将会提高 科学的批判性思维,并为建立联系和展示我的成果提供机会。这些将是 通过咨询委员会一年两次的评价、出席国家会议、出席 杂志俱乐部,改善格兰特精神,并出版由拟议工作产生的手稿。我的同事- 导师还将提供与成功的独立研究实验室的正确方向相关的培训。总而言之, 我期望这项提案中详述的活动将提供一个开始的特殊环境。 独立的职业生涯。
英文摘要
This career development award proposal aims to define potential mechanisms that predict outcome after traumatic brain injury (TBI), while at the same time providing the applicant with training opportunities within the VA. TBI affects approximately 15% military population. Veterans were subjected to repeated TBI are at increased risk of developing long-term neurodegenerative disorders. Treatment options are limited, mainly because the pathology behind neurological deficits due to TBI is poorly understood. Apolipoprotein E (ApoE) has several alleles, and patients that express the E4 allele have worse outcomes, particularly in the long term after TBI. Despite a wide range of studies centered on the ApoE4 allele, none can be found that investigate the influence of a major ApoE receptor, low density lipoprotein related protein 1 (LRP1), on outcomes after TBI. Nevertheless, evidence suggests that LRP1 can play a role in modulating TBI outcome- -LRP1 removes a large variety of cellular proteins, both from the plasma membrane and in the cytosol, and plays an important role in determining protein expression at the plasma membrane. ApoE4 enters cells by binding to LRP1 and undergoing receptor mediated endocytosis. In contrast to other ApoE alleles (E2, E3), ApoE4 endocytosis and receptor recycling are impaired. In the case of LRP1, impaired recycling is postulated to greatly alter ability of LRP1 to act as a clearance receptor, therefore changing the milieu of proteins expressed on the plasma membrane and so altering cellular response to damage. For this proposal, I am focused on understanding the contribution of LRP1 to TBI pathology in a single cell type, astrocytes. Not only are astrocytes the primary producers of ApoE in the brain, they also play a tremendous role in determining outcome by limiting secondary spread of damage after TBI. My working hypothesis is that critical LRP1 function is disrupted by ApoE4 binding in astrocytes, thereby modulating normal cellular responses and sensitizing the brain to inflammation and cell death after TBI. My research strategy will test this hypothesis while also providing clear training objectives and career opportunities in order to develop independence. Aim 1 tests the hypothesis that loss of astrocyte LRP1 worsens outcome in TBI. Astrocyte-specific LRP1 mice have been generated, and mouse TBI models will test outcome in the acute and chronic outcome. Aim 2 will test the hypothesis that the impact of ApoE4 on TBI outcome depends on LRP1. TBI-like cell culture models will mechanistically test the influence of ApoE4 and LRP1 on cell survival. One new mouse line will be generated by crossing ApoE4 targeted replacement mice into the astrocyte-LRP1 knockout model, and then the effect on outcome after TBI will be tested similar to aim 1. Aim 3 tests the hypothesis that ApoE4 worsens outcome by increasing signaling through the inflammatory tumor necrosis alpha receptor 1 (TNFR1), elevating cytokine stimulated cell death. This aim will be tested mechanistically using cell culture models to test the influence of ApoE4 and LRP1 on TNFR1 plasma membrane expression, recycling, and TNFR1-mediated cell death. My career goal is to become a successful independent investigator within the VA system, eventually obtaining MERIT funding and contributing to better outcomes in Veterans with TBI. I have assembled a team that includes experts in the field of LRP1 biology, neuroscience, and most importantly, TBI. The scientific objectives will prepare me for a career studying the effects of TBI in mouse models, while the career objectives will improve scientific critical thinking and provide opportunities for networking and presentation of my results. These will be achieved via biannual evaluation by the advisory committee, attendance at national conferences, attending journal club, improving grantsmanship, and publishing manuscripts resulting from the proposed work. My co- mentors will also provide training related to proper direction of a successful independent research lab. Altogether, I expect that the activities detailed in this proposal will provide an exceptional environment from which to start an independent career.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3171/2018.12.focus18206
发表时间: 2019-03
期刊: Neurosurgical focus
影响因子: 4.1
作者: [D. Wallace;Naomi L. Sayre;T. T. Patterson-T.;Susannah E. Nicholson;D. Hilton;Ramesh Grandhi;Ramesh Grandhi]
通讯作者: D. Wallace;Naomi L. Sayre;T. T. Patterson-T.;Susannah E. Nicholson;D. Hilton;Ramesh Grandhi;Ramesh Grandhi
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
海外基金